For Investors

Peptomyc’s business model consists of de-risking Omomyc-CPP from a Proof of Concept Development Stage into a successful Phase I/II product and then Licensing it to a Pharmaceutical company.

Peptomyc is currently looking for investors in order to fund the pre-clinical development of Omomyc. Should you have any enquiries please contact lsoucek@peptomyc.com.